Keros Therapeutics to receive $20M milestone from Takeda
Go back to Keros Therapeutics to receive $20M milestone from Takeda| (NASDAQ: KROS) | Delayed: 11.17 -0.14 (1.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.31 | 52 Week High | $ | |||
| Open | $11.16 | 52 Week Low | $ | |||
| Day High | $11.20 | P/E | N/A | |||
| Day Low | $11.00 | EPS | $ | |||
| Volume | 128,792 | |||||
| (NYSE: TAK) | Delayed: 18.11 -0.1 (0.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.21 | 52 Week High | $0.55 | |||
| Open | $18.34 | 52 Week Low | $0.55 | |||
| Day High | $18.34 | P/E | N/A | |||
| Day Low | $18.10 | EPS | $-0.20 | |||
| Volume | 1,749,287 | |||||
